z-logo
open-access-imgOpen Access
Impact of Astroglial Connexins on Modafinil Pharmacological Properties
Author(s) -
Adeline Duchêne,
Magali Perier,
Yan Zhao,
Xinhe Liu,
Julien Thomasson,
Frédéric Chauveau,
Christophe Piérard,
D. Lagarde,
Christèle Picoli,
Tiffany Jeanson,
Franck Mouthon,
Yves Dauvilliers,
Christian Giaume,
JianSheng Lin,
Mathieu Charvériat
Publication year - 2016
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.5854
Subject(s) - modafinil , pharmacology , narcolepsy , connexin , neuroscience , flecainide , medicine , chemistry , psychology , gap junction , biochemistry , intracellular , atrial fibrillation
Modafinil is a non-amphetaminic wake-promoting compound used as therapy against sleepiness and narcolepsy. Its mode of action is complex, but modafinil has been recently proposed to act as a cellular-coupling enhancer in glial cells, through modulation of gap junctions constituted by connexins. The present study investigated in mice the impact of connexins on the effects of modafinil using connexin inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom